Accelerate Diagnostics, Inc.
Index- P/E- EPS (ttm)-0.97 Insider Own0.80% Shs Outstand87.01M Perf Week-5.95%
Market Cap71.41M Forward P/E- EPS next Y-0.54 Insider Trans12.73% Shs Float72.59M Perf Month4.15%
Income-70.50M PEG- EPS next Q-0.15 Inst Own27.80% Short Float / Ratio6.15% / 15.40 Perf Quarter-46.15%
Sales13.10M P/S5.45 EPS this Y9.80% Inst Trans43.04% Short Interest4.46M Perf Half Y-68.40%
Book/sh-0.11 P/B- EPS next Y30.30% ROA-97.90% Target Price2.00 Perf Year-76.05%
Cash/sh0.53 P/C1.29 EPS next 5Y30.00% ROE172.30% 52W Range0.46 - 3.74 Perf YTD-4.66%
Dividend- P/FCF- EPS past 5Y0.60% ROI-84.70% 52W High-81.99% Beta1.09
Dividend %- Quick Ratio6.40 Sales past 5Y116.80% Gross Margin29.20% 52W Low45.00% ATR0.07
Employees220 Current Ratio6.90 Sales Q/Q-3.20% Oper. Margin- RSI (14)44.83 Volatility10.25% 9.67%
OptionableYes Debt/Eq- EPS Q/Q-22.80% Profit Margin- Rel Volume0.38 Prev Close0.69
ShortableYes LT Debt/Eq- EarningsNov 14 AMC Payout- Avg Volume289.70K Price0.67
Recom2.00 SMA20-5.16% SMA50-5.49% SMA200-41.81% Volume45,052 Change-2.32%
Mar-09-22Downgrade Craig Hallum Buy → Hold $5
Oct-08-20Initiated BTIG Research Neutral
Aug-07-20Upgrade Craig Hallum Hold → Buy $20
Sep-27-19Downgrade JP Morgan Neutral → Underweight $16
Nov-07-18Downgrade JP Morgan Overweight → Neutral
May-24-18Initiated Craig Hallum Hold $25
Dec-13-17Downgrade BTIG Research Buy → Neutral
Jul-12-17Resumed BTIG Research Buy $34
Mar-24-16Initiated JP Morgan Overweight $17
Dec-16-15Initiated Piper Jaffray Overweight
Feb-06-23 05:23AM
Dec-19-22 01:32PM
Nov-16-22 10:22AM
Nov-14-22 04:05PM
Oct-24-22 01:52PM
10:02AM Loading…
Oct-19-22 01:27PM
Aug-23-22 08:02AM
Aug-19-22 04:50PM
Aug-18-22 09:30PM
Aug-17-22 06:00PM
Aug-15-22 02:41PM
07:09AM Loading…
Jul-28-22 07:09AM
Jul-25-22 09:30AM
Jul-11-22 08:00AM
Jun-13-22 06:55AM
May-23-22 09:30AM
May-16-22 06:15PM
May-12-22 06:25PM
May-10-22 05:55PM
May-05-22 09:00AM
May-04-22 08:25AM
Apr-29-22 09:30AM
Apr-25-22 08:41AM
Mar-28-22 08:05AM
06:15AM Loading…
Mar-15-22 06:15AM
Mar-08-22 05:45PM
Feb-24-22 09:30AM
Feb-15-22 03:01PM
Feb-10-22 05:55PM
Feb-02-22 09:30AM
Jan-31-22 05:05AM
Jan-28-22 09:38AM
Jan-13-22 09:15AM
Jan-12-22 09:15AM
Dec-29-21 09:30AM
Dec-01-21 04:07AM
Nov-27-21 06:35AM
Nov-22-21 07:00AM
Nov-09-21 06:55PM
Nov-02-21 03:01PM
Oct-21-21 08:07AM
Oct-19-21 08:00AM
Sep-30-21 08:36PM
Sep-29-21 08:31AM
Sep-28-21 06:29AM
Sep-23-21 09:15AM
Aug-05-21 08:35PM
Aug-03-21 08:00AM
Jul-30-21 10:28AM
Jul-29-21 03:05PM
Jul-15-21 08:00AM
Jul-08-21 06:31AM
Jul-07-21 08:00AM
Jun-30-21 10:05AM
Jun-22-21 08:00AM
Jun-21-21 11:11PM
May-19-21 08:00AM
May-17-21 02:18AM
May-06-21 07:05PM
May-05-21 02:34PM
Apr-29-21 05:03PM
Apr-01-21 06:22AM
Feb-28-21 01:02AM
Feb-23-21 02:30PM
Feb-06-21 01:25AM
Feb-01-21 08:00AM
Jan-29-21 10:14AM
Jan-28-21 06:17PM
Jan-12-21 06:00AM
Dec-14-20 07:07AM
Nov-07-20 07:53AM
Nov-05-20 04:29PM
Oct-29-20 12:35PM
Oct-15-20 06:38AM
Oct-12-20 09:05AM
Sep-16-20 09:00AM
Sep-10-20 09:00AM
Aug-24-20 09:15AM
Aug-19-20 10:30AM
Aug-18-20 04:15PM
Jul-30-20 12:33PM
Jul-17-20 07:00AM
Jul-16-20 08:00AM
Jun-25-20 06:26PM
Jun-15-20 09:20AM
May-29-20 12:00PM
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Phillips JackChief Executive OfficerFeb 01Option Exercise0.0010,0000260,843Feb 01 05:38 PM
REICHLING STEVENChief Financial OfficerJan 13Option Exercise0.009,439076,932Jan 17 05:18 PM
Phillips JackChief Executive OfficerJan 13Option Exercise0.0017,2160259,251Jan 17 05:18 PM
Phillips JackChief Executive OfficerJan 13Sale0.698,4085,802250,843Jan 17 05:18 PM
REICHLING STEVENChief Financial OfficerJan 13Sale0.694,7303,26472,202Jan 17 05:18 PM
Mertz Larry MichaelChief Technology OfficerAug 30Buy1.6050,00080,000433,411Aug 30 03:15 PM
Mertz Larry MichaelChief Technology OfficerAug 22Buy1.3551,74969,861383,411Aug 22 03:30 PM
REICHLING STEVENChief Financial OfficerAug 22Buy1.395,0006,95067,493Aug 22 11:52 AM
Phillips JackChief Executive OfficerJun 22Option Exercise0.0062,1600270,233Jun 24 04:14 PM
Phillips JackChief Executive OfficerJun 22Sale0.9128,19825,660242,035Jun 24 04:14 PM
REICHLING STEVENChief Financial OfficerApr 28Sale0.9829,91529,31762,493Apr 28 05:58 PM
Phillips JackChief Executive OfficerApr 28Sale0.9883,70882,034208,073Apr 28 05:54 PM
REICHLING STEVENChief Financial OfficerApr 26Option Exercise0.0057,736092,408Apr 28 05:58 PM
Phillips JackChief Executive OfficerApr 26Option Exercise0.00168,3960291,781Apr 28 05:54 PM
Price RonHead of Commercial OperationsApr 22Sale0.9815,07214,77140,610Apr 25 05:31 PM
Price RonHead of Commercial OperationsApr 21Option Exercise0.0040,755055,682Apr 25 05:31 PM